CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-24 | Logal Adam Sr. Vice President, CFO | Shares withheld for taxes | −53,266 | $1.22 | $65K | 563,396 |
| 2025-05-27 | Logal Adam Sr. Vice President, CFO | Grant or award · Stock Option (Right to Buy) | +437,500 | 437,500 | ||
| 2024-07-24 | Logal Adam Sr. Vice President, CFO | Grant or award | +437,500 | 616,662 | ||
| 2023-05-18 | Logal Adam Sr. Vice President, CFO | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2021-02-19 | Logal Adam Sr. Vice President, CFO | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2020-06-04 | Logal Adam Sr. Vice President, CFO | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2019-07-01 | Logal Adam Sr. Vice President, CFO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 |
Page 1 of 1 · 7 trades